Neuropsychopharmacology to the next generation: New wave from Asia October 11-13, 2019 Fukuoka, Japan torres: Center” Chair: Kazutaka Ikeda (Tokyo Metropolitan Institute of Medical Science) Vice Chair: Kazutaka Shimoda (Dokkyo Medical University) Toshiyuki Someya (Niigata University) Secretary: Shinya Kasai (Tokyo Metropolitan Institute of Medical Science) Joint Annual Meetings 9 7) * JSCNP ~... | JSNP 29th Annual Meeting of 49th Annual Meeting of, Japanese Society of Japanese Society of we Clinical Neuropsychopharmacology Neuropsychopharmacology. Chair: Reiji Yoshimura Chair: Hisatsugu Miyata ati trend rman Fal) | (ae User Shan of Motion) Bre ue Peon Biomterutr curiae ens Hitotsubashi, Chiyoda-ku, 003, ed Peat) mene ayGuideline for symposia submissions To ensure your submision meets the criteria for acceptance, please read trough the follwing information before submiting y8, YT | October 31, 2018 12:00 EDT (1600 DE a <7 | Please download the symposium propesal format from AsCNP2018 website and ‘submit the filled form to the secretariat at asenp2018@aeplan.co jp. a, ‘ASCNP2019 website: http//wwn2-seplan.co jp/asene/ 8 eae General information / ee te > Each symposium ssc for 1 hour and 40 minutasin length, > Each symposiom ie composed of two char, three or four speakers, and two dicutrant > Three or four speakers inclang the chairs should representa last ep liffarent curing. High diverts of 938 gender and GesecaSb ‘ofthe speakers are greatly encouraged. Symposium proporals that include both genders and younger speaker) are prefer. > Symposium mut be organized by an AECNP member“ An organizer cannot submit more than ene symposium and an individual cannot participate in more than two proporals a a hai, speaker andor discussant > Symposium organizer must act asa chair inthe proposed symposium. A coxhair willbe designated by the program committee afershe selection of symposia > Discussants canbe designated by the symposium organizer or can be let undesignated. Ho dscussans ae listed inthe proposal, the program committee wil designate discussant > The chairs, speakers and discussant of symposia should register and pay the registration fee for ASCNP2018, > Sympesm support grant of JPY 300,00 wl be provided for each accepted proposal. xcept forthe symposivm support grant, ACNP2O1S assumes no financa responsibility for any ofthe expenses for chars, speakers and discussant of symposia to attend the congress > Allsymposium proposals mus be submitedby the deadline of October 3, 2018 at 12:0 EDT (16:00 GN). Pease not helt submisions wil nat ae considered forthe symposium propel Al proposals willbe reviewed by the scent rogram committee and notifications willbe sent oa symposia organizers by end of December 2018 > Symposium organizes and all speakers must assume responsibly forthe symposium propor > The program committee may ask tne organizers to madify ther proposals in the selection proces, if necessary. > There ia high possibility that candidate speakers of rejected symposia will be selected for presentations at “Excellent Oral Seisions™ and ill receive travel grant of JPYS0,000 “1: The ASCNP is comprised of some classes of membership. Please see and check your AsCNP membership in the ASCNP homepage: httpdJ/ascnp orgimembershiplindexhtml Requirements for proposal submission / > All symposia proposals must be submitted in English, > Symposium title and a 500-word abstract including background and objective of the symposium > Topie(s that characterizes the proposed symposium (more than one topic can be chosen from the topic list) > Tentative titles of all Individual presentations in the proposed symposium | > Up to3 representative publications of each speaker (not mandatory) > Name, affiliation, email address, country, gender and age (40 and under J over 40) of organizer, speakers and discussants > By submitting a symposium, organizer must obtain consent from all speakers and discussants for thelr presence in the symposium. TOPICS =~ ‘The AsCNP International Scientific Programme Committee welcomes the proposal of symposia that focus on the latest developments in preclinical, clinical aswell as translational research, especially in Asia. The ASCNP has special interests in new approaches to the development and assessment of CNS pharmaceuticals and encourages participation of researchers and clinicians in academia, industry and hospitalseinc. Research By disorder By drug & methodology neal ‘alicive dvordere Drugs Yer depresion Antdepressans Precincal Anaety Disorders ‘Avimal Models “Tranlations [tention Deft Dliorders Drugs for pschosis (Antipsychotics) others Bipolar Disorders Ansialyies Childnood & Adolescent Disorders Dementia Brain Stimulation Ethics in Pryehopharmacalogy Depression “Genetics Eating Disorders Hirtory of Pychopharmacology Eplepsy Hypnotis (ObsesiveCompulive Disorders Imaging Perionalty Dborders Pos-raumati Stes Disorders Premenstrual Synarome Molecular Neurobslogy Pharmacology Mood Stabilize Neuropathology / Post Mortem Stu Neurophysiology Séhizophrenia ‘rental Mecicine Sexual Diorders Pharmacoeconomict, Sleep Disorders Pharmacogenets/ kinetics ‘uldde Psychoneuroimmunslogy others ‘Transcultural Pyehopharmacalogy Computational Neurosience ‘others